12 min read
5.0
104

Insulin Resistance Symptoms in Women: Signs, What They Mean, and When to Get Tested

Central weight gain, fatigue, skin changes, and PCOS features can point toward insulin resistance — but only clinician-ordered blood tests confirm it.

Jane Smorodnikova
Founder & CEO
Kseniia Iaroslavtseva
COO & Strategy team teamlead
Anna Elitzur
Medical Advisor
Insulin resistance is often silent: the pancreas can make extra insulin and keep blood sugar in range for years, so there may be nothing to feel. When signs do appear they are non-specific — central weight gain, post-meal fatigue and cravings, skin tags, and dark velvety skin (acanthosis nigricans) — and in women they often run through PCOS (irregular periods, acne, excess hair growth), where insulin resistance is commonly reported in about 44-70% of patients depending on how it is defined. None of these prove insulin resistance, prediabetes, or diabetes; those are diagnosed only by clinician-ordered blood tests (HbA1c, fasting plasma glucose, sometimes fasting insulin/HOMA-IR). Welltory does not measure blood glucose; it tracks heart rate, HRV, sleep, and stress and cannot diagnose these conditions. Very high blood sugar with signs of diabetic ketoacidosis, or symptoms of low blood sugar, need urgent medical care.

Short Answer

Insulin resistance symptoms in females can be frustrating because insulin resistance is often silent: your pancreas may keep blood sugar in range for years, so there may be nothing obvious to “feel.” When clues do show up, they’re usually patterns rather than proof — more weight around the middle, changes in weight that feel harder to explain, fatigue or energy crashes, increased hunger or cravings, skin tags, or dark, velvety skin in folds such as the neck, armpits, or groin. That darker skin change is called acanthosis nigricans, and it’s one of the more specific visible signs linked with insulin resistance, prediabetes, or type 2 diabetes. (niddk.nih.gov)

In women, insulin resistance often sits in the same body system as polycystic ovary syndrome (PCOS). PCOS can add irregular or missed periods, acne, and unwanted coarse hair growth because higher insulin can push ovarian androgen signaling higher; studies commonly report insulin resistance in about 44–70% of people with PCOS, though the exact number depends on how PCOS and insulin resistance are defined. (my.clevelandclinic.org)

These symptoms are non-specific. Stress, sleep debt, thyroid disease, anemia, depression, medications, perimenopause, and many other conditions can look similar from the outside. So the useful next step is not self-diagnosis — it’s testing. Clinicians usually check blood-based markers such as HbA1c and fasting plasma glucose to look for prediabetes or diabetes; if they’re specifically evaluating insulin resistance, they may also consider fasting insulin or a calculated index such as HOMA-IR, but insulin-resistance testing is not a simple routine yes/no test. A wearable like Welltory does not measure blood glucose — it tracks heart rate, HRV, sleep, and stress — so it can’t confirm or rule out insulin resistance, but noticing patterns in how your body handles strain can be a useful nudge to ask a clinician for bloodwork. (niddk.nih.gov)

Insulin resistance signs at a glance

Insulin resistance is often silent. If your pancreas can make enough extra insulin to keep blood sugar in range, you may not feel anything at all; it may show up only through risk factors, skin changes, or bloodwork. So read these as clues, not proof — the next step is clinician-ordered testing, not self-diagnosis. (niddk.nih.gov)

SignWhat it looks likeClass
Central weight gainFat that is hard to lose around the abdomen or waist. This can travel with insulin resistance because insulin and fat tissue talk to each other metabolically — but waist changes are also shaped by sleep, stress, medications, menopause, thyroid disease, activity, alcohol, and total energy intake.Common, non-specific. Useful as a “get checked” clue, not a diagnosis. NIDDK notes that insulin resistance can be linked with increased blood glucose and weight gain, while Mayo describes waist size as one of the signs clinicians may look at in an insulin-resistance workup. (niddk.nih.gov)
Post-meal fatigue & cravingsAn energy crash, sleepiness, or wanting something sweet after eating. This can happen when your body is struggling to handle a meal, but it can also come from meal composition, poor sleep, long gaps between meals, stress, or normal dips in alertness.Common, non-specific. Fatigue can appear when blood sugar becomes consistently high, but “I crash after lunch” alone cannot tell you whether you have insulin resistance. (my.clevelandclinic.org)
Acanthosis nigricansDarker, thicker, velvety-feeling skin, often in folds such as the back of the neck, armpits, groin, elbows, or knuckles. It may develop slowly and can be mistaken for “dirty” skin, but it does not wash off.More specific skin sign. Acanthosis nigricans is a recognized skin manifestation associated with insulin resistance, obesity, diabetes, and some endocrine conditions. Sudden or rapidly changing patches should be checked promptly because acanthosis can rarely be linked with other serious causes. (medlineplus.gov)
Skin tagsSmall, soft, flesh-colored or darker skin growths, often on the neck, armpits, eyelids, under the breasts, or groin. They may show up alongside acanthosis nigricans.Associated. Skin tags are common and usually harmless, but multiple skin tags — especially with acanthosis nigricans or other metabolic risk factors — can be a reason to ask about blood sugar and insulin-resistance testing. (pmc.ncbi.nlm.nih.gov)
PCOS features (women)Irregular or skipped periods, acne, excess facial/body hair growth, scalp hair thinning, or fertility problems. In the body, high insulin can interact with ovarian androgen production, which is one reason PCOS and insulin resistance often overlap.Strongly linked to insulin resistance. In PCOS literature, insulin resistance is commonly cited as affecting about 44–70% of patients when surrogate markers are used, but it is not universal — some women with PCOS have normal insulin sensitivity. (pmc.ncbi.nlm.nih.gov)
High fasting insulin / HOMA-IRYou do not feel this. It shows up only on bloodwork, usually when a clinician orders fasting insulin with fasting glucose and calculates or interprets insulin-resistance markers.Clinician-ordered marker. HOMA-IR is a lab-derived estimate based on fasting insulin and fasting glucose; it is useful in research and some clinical contexts, but it is still a surrogate marker and should be interpreted with your overall health picture, not as a stand-alone “symptom.” (ncbi.nlm.nih.gov)

Why insulin resistance is often symptom-free

The tricky part about insulin resistance is that you usually can’t feel it at first. Your muscle, fat, and liver cells are responding less strongly to insulin, but your pancreas can often cover for that by making more insulin. As long as it can keep up, your blood glucose may stay in a normal range — and you may feel completely fine. (niddk.nih.gov)

That’s why “insulin resistance symptoms” are an unreliable early warning system. The problem can build quietly for years before glucose rises enough to cause more noticeable signs, such as unusual thirst, frequent urination, fatigue, or unexplained weight change. By that point, the issue may be closer to prediabetes or type 2 diabetes than early insulin resistance. (my.clevelandclinic.org)

So the body story is simple: first, your pancreas works harder; later, if it can’t compensate anymore, blood sugar starts to drift upward. You don’t test because symptoms prove insulin resistance. You test because symptoms often don’t.

The common (but non-specific) signs

The signs people most often notice are frustratingly general: weight that collects around the middle and resists dieting; fatigue, brain fog, and sugar cravings, especially after carb-heavy meals; and increased hunger. Your body may be working harder to keep blood sugar in range, so you can feel “off” without having one clean, obvious symptom. But this is the catch: insulin resistance and prediabetes often have no symptoms at all, and when symptoms do show up, they can look like diabetes symptoms — tiredness, hunger, thirst, frequent urination, blurred vision — or like many non-glucose problems. None of these prove insulin resistance on their own. They overlap with stress, poor sleep, thyroid problems, medication effects, and ordinary life. That is why they should push you toward a clinician-ordered blood test, not toward a self-diagnosis. (niddk.nih.gov)

A more telling physical sign is on the skin. Acanthosis nigricans — dark, thickened, velvety patches in skin folds such as the back or sides of the neck, armpits, or groin — is linked with insulin resistance, diabetes, and obesity. Skin tags can appear in the same areas. These changes still do not diagnose you by themselves, but they are specific enough that they deserve a medical check-in and blood sugar testing, especially if they are new, spreading, or paired with other risk factors. (medlineplus.gov)

Insulin resistance symptoms in women — the PCOS connection

In women, insulin resistance can be especially hard to “feel” directly. Your blood sugar may still look normal for a while because your pancreas is pushing out more insulin to keep glucose in range, and NIDDK notes that people with insulin resistance and prediabetes usually have no symptoms. That is why clinician-ordered blood tests matter. But if PCOS is part of the picture, your body may give you a different set of clues: irregular or absent periods, acne or oily skin, excess hair growth on the face, chin, chest, abdomen, or thighs, thinning scalp hair, fertility trouble, weight gain or difficulty losing weight, darkened skin folds, and skin tags. NICHD and the FDA describe PCOS as a hormonal condition that can show up across menstrual, skin, hair, fertility, and metabolic symptoms — not just in the ovaries. (niddk.nih.gov)

The overlap is not incidental. PCOS is an endocrine-metabolic condition, and insulin resistance can sit inside the same loop as androgen excess and ovulation disruption. As one 2026 review puts it, PCOS is “a heterogeneous endocrine-metabolic disorder in which reproductive dysfunction coexists with insulin resistance, chronic low-grade inflammation, and heightened oxidative stress” (Redox-endocrine triad in PCOS, 2026). (pmc.ncbi.nlm.nih.gov) High androgen levels can interfere with ovulation and drive acne and unwanted hair growth; high insulin levels are also common in PCOS and can raise the risk of prediabetes and type 2 diabetes over time. (womenshealth.gov)

And it is common: one 2026 study reports that “insulin resistance (IR) is commonly observed in patients with polycystic ovary syndrome (PCOS), affecting 44% to 70% of these individuals” (Kisspeptin improves local ovarian insulin resistance in PCOS, 2026). (pmc.ncbi.nlm.nih.gov) Still, that range should not be read as “every woman with PCOS has insulin resistance.” Reviews note that estimates vary because PCOS criteria, populations, and insulin-resistance testing methods differ, and some women with PCOS have normal insulin sensitivity. (pmc.ncbi.nlm.nih.gov)

So for many women, the route to recognizing possible insulin resistance runs through reproductive and skin symptoms as much as through weight, hunger, or energy. If you are searching for insulin resistance symptoms in females because your cycle has changed, acne has become persistent, facial hair is increasing, or dark velvety skin has appeared in body folds, treat those signs as a reason to talk with a clinician — not as a self-diagnosis. The next step is testing: glucose, A1C, and sometimes additional metabolic or hormone labs, depending on your history.

When symptoms mean it's progressed — high blood sugar and complications

If insulin resistance has already tipped into diabetes-range blood sugar, the signal often stops feeling subtle. You may notice stronger thirst, peeing more often, blurred vision, unusual fatigue, slow-healing cuts, frequent infections, or tingling/numbness in your hands or feet — symptoms that fit high blood glucose rather than insulin resistance alone. They still don’t diagnose diabetes by themselves, but they are a clear reason to ask a clinician about blood testing. (niddk.nih.gov)

One complication worth naming early is the kidneys. Diabetes is a leading cause of kidney disease, and diabetic kidney disease can stay quiet for a long time because many people have no symptoms at first. That’s why clinicians don’t wait for “kidney disease diabetes symptoms” to appear — they screen with urine albumin testing and a blood test that estimates how well your kidneys are filtering. NIDDK recommends yearly kidney testing for people with type 2 diabetes, and for people with type 1 diabetes after they’ve had it for more than 5 years. (niddk.nih.gov)

When kidney-related warning signs do show up, they can include swelling in the feet or ankles, foamy urine, worsening fatigue, itching or dry skin, or other signs of fluid and waste buildup. These symptoms can come from many causes, but in someone with diabetes-range blood sugar or known diabetes, they belong with a clinician promptly — not as something to watch for months. (niddk.nih.gov)

"Signs insulin resistance is reversing" — read this carefully

A common search is for signs that insulin resistance is improving. Honestly: you can’t reliably read reversal from symptoms, and you shouldn’t try to. Insulin resistance and prediabetes often have no symptoms at all; your pancreas may still be pushing out enough insulin to keep blood sugar in range, so your body can look “fine” on the outside while the workload is still high on the inside. Feeling better, losing central weight, having steadier energy, fewer cravings, or clearer skin can happen alongside improvement — but they are not proof that insulin resistance is reversing. (niddk.nih.gov)

The real evidence is in clinician-ordered numbers. Depending on your situation, that may include HbA1c, fasting plasma glucose, an oral glucose tolerance test, fasting insulin, or a calculated HOMA-IR; HbA1c is used to diagnose and monitor diabetes and prediabetes, while fasting insulin is interpreted together with your history and other blood tests, including glucose. HOMA-IR can be useful in research and some clinical contexts, but it is not a routine stand-alone diagnosis for most people — so ask your clinician which markers actually make sense for you. (cdc.gov)

In studies, improvement shows up as measurable marker changes, not as a symptom checklist — for example, lifestyle-intervention research has linked better outcomes with objective changes such as HbA1c improvement, weight loss, and lower measured insulin resistance rather than with how people say they feel. (pmc.ncbi.nlm.nih.gov)

So track how you feel, but don’t use symptoms as your scoreboard. Use them as signals: “My energy is steadier,” “my waist is changing,” “my skin is clearer,” “my hunger feels less urgent.” Then confirm progress with testing. If the numbers are improving, your body is likely needing less compensation from insulin. If the symptoms feel better but HbA1c, fasting glucose, fasting insulin, or other clinician-chosen markers are not improving, you still have useful information — it just means the next step is medical follow-up, not self-diagnosis.

When to get tested — and what testing looks like

Because insulin resistance symptoms in females are so non-specific, the practical move is testing, not self-diagnosis. Fatigue, cravings, weight changes, skin darkening, irregular periods, or “something feels off after meals” can all come from more than one body system. They may be related to glucose and insulin, but they can also overlap with thyroid issues, anemia, sleep debt, stress, PCOS, medication effects, and other conditions. See a clinician if you have several signs together, especially if you also have a parent or sibling with type 2 diabetes, PCOS, a history of gestational diabetes, overweight or obesity, or other diabetes risk factors. CDC lists family history, PCOS, and prior gestational diabetes among risk factors for prediabetes or type 2 diabetes, and NIDDK notes that people with insulin resistance or prediabetes often have no symptoms at all — which is why waiting for a “clear sign” can miss the window for early action. (cdc.gov)

Testing is clinician-ordered and usually starts with blood work, not an app readout. HbA1c reflects your average blood glucose over roughly the past 3 months; fasting plasma glucose shows your glucose at that moment after an overnight fast. For prediabetes, NIDDK lists HbA1c 5.7%–6.4% or fasting plasma glucose 100–125 mg/dL; diabetes-range results include a “fasting blood glucose level ≥126 mg/dL, glycated hemoglobin level ≥6.5%” (Aichi Worker’s Cohort Study, 2026). Diagnosis may need confirmation with repeat or additional lab testing, depending on the result and clinical context. (niddk.nih.gov) (pmc.ncbi.nlm.nih.gov)

If your clinician wants to look more directly at insulin resistance itself, they may use calculated markers such as HOMA-IR or the triglyceride-glucose, or TyG, index. These are estimates built from lab values — for example, fasting glucose with fasting insulin for HOMA-IR, or fasting glucose with triglycerides for TyG — not standalone “yes/no” diagnoses you can read from symptoms. NCBI’s Endotext describes HOMA as a practical surrogate index used when direct insulin-sensitivity testing is not needed or feasible, and research reviews describe TyG as another surrogate marker, with cutoffs that can vary by population. (ncbi.nlm.nih.gov)

A wearable or app can still be useful in the conversation. Patterns in heart rate, HRV, sleep, stress, activity, and how you feel after meals can help you notice when your body is under strain and give your clinician better context. But those patterns cannot diagnose insulin resistance, prediabetes, or diabetes. Welltory specifically does not measure blood glucose — it tracks heart rate, HRV, sleep, and stress — so use it as a “what should I bring up?” tool, not as a blood sugar test.

When it's an emergency

Some blood-sugar situations need urgent care, not watchful waiting. Very high blood sugar with fruity-smelling breath, fast deep breathing, vomiting, severe tiredness, or confusion can signal diabetic ketoacidosis (DKA) — a medical emergency. Low blood sugar can also become dangerous quickly: shaking, sweating, dizziness, confusion, trouble walking or seeing clearly, seizures, or fainting need prompt action and, when severe, emergency care. If you have any of these emergency symptoms, do not wait for an app, an article, or an appointment slot — seek immediate medical attention or call your local emergency number. (cdc.gov)

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

This article is for education only. Symptoms of insulin resistance are non-specific and overlap with many conditions, so this page cannot tell you whether you have insulin resistance, prediabetes, or diabetes — only clinician-ordered blood tests can. Welltory does not measure blood glucose and cannot diagnose these conditions. If you have very high blood sugar with signs of diabetic ketoacidosis, or symptoms of low blood sugar, seek urgent medical care.

Was this helpful?

Ask AI for a summary of page

ChatGPTGeminiClaudePerplexityGrok

Written by Jane Smorodnikova

The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.

Written by Kseniia Iaroslavtseva

She reviews scientific research and turns it into structured, readable insights.

Reviewed by Anna Elitzur

With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.

References

  1. Insulin resistance in PCOS 44–70% — Kisspeptin improves local ovarian insulin resistance in PCOS by modulating the PI3K/AKT/GLUT4 signaling pathway. PLoS One. 2026. PMCID: PMC12863573. https://pmc.ncbi.nlm.nih.gov/articles/PMC12863573/
  2. PCOS as an endocrine-metabolic disorder with insulin resistance — Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails? Front Endocrinol. 2026. DOI: 10.3389/fendo.2026.1825853; PMCID: PMC13160802. https://pmc.ncbi.nlm.nih.gov/articles/PMC13160802/
  3. PCOS insulin-resistance estimates vary by criteria — Insulin resistance in PCOS: methodology and prevalence review. PMCID: PMC3687487. https://pmc.ncbi.nlm.nih.gov/articles/PMC3687487/
  4. T2D diagnostic thresholds: fasting blood glucose ≥126 mg/dL / HbA1c ≥6.5% — Association of Adipose Tissue Insulin Resistance With Risk of Diabetes Incidence in Middle-aged Japanese Workers: Aichi Worker’s Cohort Study. PMCID: PMC12698324. https://pmc.ncbi.nlm.nih.gov/articles/PMC12698324/
  5. Lifestyle intervention / marker-based improvement in insulin resistance — Type 2 diabetes remission and its predictors in an Indian cohort: A retrospective analysis of an intensive lifestyle intervention program. PMCID: PMC12543109. https://pmc.ncbi.nlm.nih.gov/articles/PMC12543109/
  6. HOMA-IR original description — Matthews DR, et al. Homeostasis model assessment. Diabetologia. 1985. PMID: 3899825. https://pubmed.ncbi.nlm.nih.gov/3899825/
  7. HOMA / TyG as surrogate markers of insulin resistance — NCBI Endotext. Insulin Resistance / surrogate indices. https://www.ncbi.nlm.nih.gov/books/NBK278954/
  8. Acanthosis nigricans, skin tags, and classic high-blood-sugar symptom coverage — Cleveland Clinic, Insulin Resistance; MedlinePlus, Acanthosis nigricans; Mayo Clinic, Acanthosis nigricans. https://my.clevelandclinic.org/health/diseases/22206-insulin-resistance
  9. Skin tags and metabolic markers — Skin tags as a marker of insulin resistance. PMCID: PMC4419263. https://pmc.ncbi.nlm.nih.gov/articles/PMC4419263/
  10. Female-specific PCOS symptom list and insulin-resistance overlap — Office on Women’s Health, Polycystic ovary syndrome; NICHD, PCOS fact sheet. https://womenshealth.gov/a-z-topics/polycystic-ovary-syndrome
  11. Prediabetes / diabetes thresholds and testing — NIDDK, Prediabetes & Insulin Resistance; NIDDK, Diabetes Tests & Diagnosis; CDC, Prediabetes A1C test; CDC, Diabetes Testing. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
  12. Diabetic kidney disease and kidney-symptom coverage — NIDDK, Diabetic Kidney Disease; NIDDK, Chronic Kidney Disease. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/diabetic-kidney-disease
  13. Diabetes risk factors — CDC, Diabetes Risk Factors. https://www.cdc.gov/diabetes/risk-factors/
  14. Diabetic ketoacidosis (emergency) — CDC, Diabetic Ketoacidosis (DKA). https://www.cdc.gov/diabetes/about/diabetic-ketoacidosis.html